Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 81 | — | COOPER COS INC | — | 54,000.0 | $3.9M | 0.37% | +4K | +8.0% | $71.71 | — |
| 82 | WAY | WAYSTAR HLDG CORP | Technology | 178,566.0 | $3.7M | 0.35% | -164K | -47.9% | $20.53 | +21.0% |
| 83 | MBX | MBX BIOSCIENCES INC | Healthcare | 62,000.0 | $3.4M | 0.32% | NEW | — | $55.20 | +20.2% |
| 84 | VCEL | VERICEL CORP | Healthcare | 70,000.0 | $3.1M | 0.29% | — | — | $44.49 | -5.3% |
| 85 | VEEV | VEEVA SYS INC | Healthcare | 17,300.0 | $3.1M | 0.29% | -68K | -79.7% | $177.47 | +41.2% |
| 86 | BCAX | BICARA THERAPEUTICS INC | Healthcare | 88,150.0 | $2.6M | 0.25% | NEW | — | $29.69 | -17.9% |
| 87 | STE | STERIS PLC | Healthcare | 11,500.0 | $2.4M | 0.23% | — | — | $210.57 | +12.0% |
| 88 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 225,000.0 | $2.2M | 0.21% | -80K | -26.2% | $9.82 | +12.9% |
| 89 | STOK | STOKE THERAPEUTICS INC | Healthcare | 64,500.0 | $2.1M | 0.20% | -18K | -22.3% | $32.72 | -4.0% |
| 90 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 33,250.0 | $2.0M | 0.19% | +5K | +18.8% | $60.36 | -1.0% |
| 91 | DOCS | DOXIMITY INC | Healthcare | 76,107.0 | $1.6M | 0.15% | -108K | -58.6% | $20.74 | +25.1% |
| 92 | PRVA | PRIVIA HEALTH GROUP INC | Healthcare | 50,000.0 | $1.3M | 0.12% | NEW | — | $25.73 | -17.6% |
| 93 | NVCR | NOVOCURE LTD | Healthcare | 70,000.0 | $1.1M | 0.10% | — | — | $15.15 | +17.3% |
| 94 | MMED | MINIMED GROUP INC | Healthcare | 55,000.0 | $822K | 0.08% | NEW | — | $14.95 | +35.0% |
| 95 | ATEC | ALPHATEC HLDGS INC | Healthcare | 85,000.0 | $735K | 0.07% | +15K | +21.4% | $8.65 | +7.4% |
| 96 | AGL | AGILON HEALTH INC | Healthcare | 5,000.0 | $536K | 0.05% | NEW | — | $107.18 | -13.5% |
| 97 | TXG | 10X GENOMICS INC | Healthcare | 8,500.0 | $326K | 0.03% | NEW | — | $38.34 | +66.6% |
| 98 | TNDM | TANDEM DIABETES CARE INC | Healthcare | 20,000.0 | $302K | 0.03% | NEW | — | $15.09 | +49.6% |
| 99 | TGTX | TG THERAPEUTICS INC | Healthcare | 5,000.0 | $275K | 0.03% | NEW | — | $54.94 | -8.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.4%